Study Group (Bemiparin +)

Control Group (Bemiparin −)

p

Live Birth

60 (93.75%)

32 (57.14%)

0.001**

Still Birth

0

0

Abortion

4 (6.25%)

24 (42.85%)

0.001**

Total

64

56